KPTIQ — Karyopharm Therapeutics Share News
0.000.00%
Last trade - 00:00- $0.39m
- $257.57m
- $146.07m
Brief: Karyopharm Therapeutics Q4 Net Income USD -30.78 Million
Karyopharm Therapeutics Inc expected to post a loss of 26 cents a share - Earnings Preview
Brief: Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Karyopharm Therapeutics Provides Endometrial Cancer Program Update
Brief: Karyopharm Therapeutics Announces The Appointment Of Chief Accounting Officer
Karyopharm Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Karyopharm Therapeutics Q3 Net Income USD -32.072 Million
Karyopharm Therapeutics Inc expected to post a loss of 26 cents a share - Earnings Preview
Primary Endpoint For Pivotal Phase 3 SENTRY Trial In Myelofibrosis
Karyopharm Therapeutics Inc expected to post a loss of 26 cents a share - Earnings Preview
Karyopharm Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Karyopharm Therapeutics Q2 Net Income USD 23.792 Million
Karyopharm Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
Brief: Karyopharm Therapeutics Inc Files For Shelf Of Up To 45.8 Million Shares Of Common Stock By Selling Stockholders - SEC Filing
U.S. RESEARCH ROUNDUP- Crescent Energy, Rockwell Automation, Transdigm Group
Karyopharm Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Karyopharm Announces Significant Refinancing Transactions
Brief: Karyopharm Therapeutics Q1 Net Income USD -37.362 Million